Professor, Internal Medicine, Mayo Medical School
Cardiology
Dr. Robert D. McBane, MD
|
|
Give Review
Robert D. McBane practices Cardiology. He attended University of North Dakota School of Medicine and Health Sciences. He over the years received 1 awards: "Fellow (FACC)". Robert McBane is a published MD. He published 95 publications, including: 'Tissue prothrombin. Universal distribution in smooth muscle.' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Coronary endothelial dysfunction is associated with increased risk of venous thromboembolism.
- Periprocedural warfarin reversal with prothrombin complex concentrate.
- Removal of floating inferior vena cava thrombus with the AngioVac device.
- The impact of gender and left Atrial blood stasis on adiponectin levels in non-valvular Atrial fibrillation.
- Prevalence and risk factors for post thrombotic Syndrome after deep vein thrombosis in children: A cohort study.
- Failure of dabigatran and rivaroxaban to prevent thromboembolism in antiphospholipid Syndrome: a case series of three patients.
- Science of health care delivery: Re: Venous thromboembolism in hospitalized patients: An updated analysis of missed opportunities for thromboprophylaxis at a universit...
- Distribution of thromboembolism in valvular versus non-valvular Atrial fibrillation.
- The role of novel anticoagulants in the management of venous thromboembolic Disease.
- Treatment of Cholesterol Embolization Syndrome in the Setting of an Acute Indication for Anticoagulation Therapy.
- Lupus anticoagulant, warfarin, and alternative laboratory monitoring of anticoagulation.
- New anticoagulant and antiplatelet agents: a primer for the gastroenterologist.
- Portal Venous Thrombosis After Distal Pancreatectomy: Clinical Outcomes.
- Outcomes and total costs of outpatient vs. inpatient peri-procedural anticoagulation management of mechanical prosthetic heart Valve patients.
- Propensity for young reticulated platelet recruitment into arterial thrombi.
- Management of antithrombotic therapy in patients undergoing invasive procedures.
- Platelet recruitment to venous stent thrombi.
- Adrenal haemorrhage due to heparin-induced thrombocytopenia.
- Three-month cumulative incidence of thromboembolism and bleeding after periprocedural anticoagulation management of arterial vascular bypass patients.
- Periprocedural anticoagulant management.
- Dabigatran: A Primer For Neurosurgeons.
- Outcomes of Venoplasty with Stent Placement for Chronic Thrombosis of the Iliac and Femoral Veins: Single-Center Experience.
- Development and initial validation of a questionnaire to diagnose the presence and severity of post-thrombotic Syndrome in children.
- Natural language processor as a tool to assess heparin induced thrombocytopenia awareness.
- Left Atrial Blood Stasis and Von Willebrand Factor-ADAMTS13 Homeostasis in Atrial Fibrillation.
- Fibrin d-dimer concentration, deep vein thrombosis symptom duration, and venous thrombus volume.
- The association of active cancer with venous thromboembolism location: a population-based study.
- Acquired and congenital risk factors associated with cerebral venous sinus thrombosis.
- Predicting left Atrial thrombi in Atrial fibrillation.
- Periprocedural anticoagulation management of patients with venous thromboembolism.
- Survival and recurrence in patients with splanchnic vein thromboses.
- Arteriovenous malformation culprit or innocent bystander?
- Inhibition of platelet-rich arterial thrombus in vivo: Acute antithrombotic effect of intravenous HMG-CoA reductase therapy.
- Peri-procedural anticoagulation management of mechanical prosthetic heart Valve patients.
- Brain lesions in cerebral venous sinus thrombosis.
- Correlation of point-of-care International Normalized Ratio to laboratory International Normalized Ratio in hemodialysis patients taking warfarin.
- Accuracy of capillary whole blood international normalized ratio on the CoaguChek S, CoaguChek XS, and i-STAT 1 point-of-care analyzers.
- Periprocedural anticoagulation management of patients with nonvalvular Atrial fibrillation.
- Treatment of venous thrombosis at unusual sites.
- Iliac venous stenting: antithrombotic efficacy of PD0348292, an oral direct Factor Xa inhibitor, compared with antiplatelet agents in pigs.
- Clinical characteristics and long-term follow-up of patients with renal vein thrombosis.
- Individual propensity for thrombosis: comparison of venous and arterial circulations.
- Platelet activation and its patient-specific consequences.
- Acute venous disease: venous thrombosis and venous trauma.
- Prognostic value of ankle-brachial index and dobutamine stress echocardiography for cardiovascular morbidity and all-cause mortality in patients with peripheral arteri...
- Association of heparin-dependent antibodies and adverse outcomes in hemodialysis patients: a population-based study.
- Cardiomyopathy associated with celiac Disease.
- Importance of device evaluation for point-of-care prothrombin time international normalized ratio testing programs.
- Direct thrombin inhibitors are not equally effective in vivo against arterial thrombosis: in vivo evaluation of DuP714 and argatroban in a porcine angioplasty model an...
- Long-term survival and amputation risk in thromboangiitis obliterans (Buerger's Disease).
- The impact of peripheral arterial Disease on circulating platelets.
- Patients with a history of type II heparin-induced thrombocytopenia with thrombosis requiring cardiac surgery with cardioPulmonary bypass: a prospective observational ...
- Factors contributing to individual propensity for arterial thrombosis.
- Influence of anatomical location on arterial thrombosis.
- Profibrinolytic, antithrombotic, and antiinflammatory effects of an insulin-sensitizing strategy in patients in the Bypass Angioplasty Revascularization Investigation ...
- Antiphospholipid antibodies in thromboangiitis obliterans.
- Reversibility of platelet thrombosis in vivo. Quantitative analysis in porcine Carotid arteries.
- Herpes esophagitis: clinical Syndrome, endoscopic appearance, and diagnosis in 23 patients.
- Antithrombotic action of endogenous porcine protein C activated with a latent porcine thrombin preparation.
- Elevated liver enzymes preceding vessel involvement in Takayasu's arteritis.
- Fechtner Syndrome: physiologic analysis of macrothrombocytopenia.
- Surgical pathology of nonbacterial thrombotic endocarditis in 30 patients, 1985-2000.
- The effects of irreversible JPEG compression on an automated algorithm for measuring Carotid artery intima-media thickness from ultrasound images.
- Antiphospholipid Syndrome and perioperative hemostatic management of cardiac valvular surgery.
- Efficacy and safety of intravenous phytonadione (vitamin K1) in patients on long-term oral anticoagulant therapy.
- Early subclinical Coronary artery calcification in young adults who were pediatric kidney transplant recipients.
- Clinical and echocardiographic measures governing thromboembolism destination in Atrial fibrillation.
- Platelet factor XIII gene expression and embolic propensity in Atrial fibrillation.
- African-American ethnicity is associated with higher plasma levels of D-dimer in adults with Hypertension.
- A patient-centered approach to the development and pilot of a warfarin pharmacogenomics patient education tool for health professionals.
- Health status after treatment for Coronary artery disease and type 2 diabetes mellitus in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.
- Comparison of PFA-100 testing and bleeding time for detecting platelet hypofunction and von Willebrand Disease in clinical practice.
- Prevalence of lower extremity venous Disease in inflammatory bowel Disease.
- Budd-Chiari Syndrome, mediastinal mass and recalcitrant leg ulcers, an unlikely trio.
- Predictors of major bleeding in peri-procedural anticoagulation management.
- Inhibition and reversal of platelet-rich arterial thrombus in vivo: direct vs. indirect factor Xa inhibition.
- Platelet characteristics associated with Coronary artery disease.
- Atrial fibrillation and thrombosis: immunohistochemical differences between in situ and embolized thrombi.
- The impact of vitamin K-dependent factor depletion by warfarin on platelet-rich thrombosis after deep arterial injury.
- Thrombophilia differences in cerebral venous sinus and lower extremity deep venous thrombosis.
- Cerebral venous sinus thrombosis: Incidence of venous thrombosis recurrence and survival.
- Aortic thrombosis as a complication of paroxysmal nocturnal hemoglobinuria.
- Fibrinogen, fibrin and crosslinking in aging arterial thrombi.
- Individual propensity for arterial thrombosis.
- Tissue prothrombin. Universal distribution in smooth muscle.
- Reduced high shear platelet adhesion to the vascular media: Defective von Willebrand factor binding to the interstitial collagen.
- Physical and enzymatic perturbation of the architecture of the Tunica media destroys its inherent thromboresistance.
- Immunohistochemistry of thrombi following iliac venous stenting: a novel model of venous thrombosis.
- Images in vascular medicine. Cross-clamp injury: an unusual cause of intermittent claudication.
- Ovarian vein thrombosis: incidence of recurrent venous thromboembolism and survival.
- Images in vascular medicine. Fibromuscular dysplasia: an atypical cause of intermittent claudication.
- Comparison of plasminogen activator inhibitor-1, tissue type plasminogen activator antigen, fibrinogen, and D-dimer levels in various age decades in patients with type...
- Comparison of PD0348292, a selective factor Xa inhibitor, to antiplatelet agents for the inhibition of arterial thrombosis.
- Images in vascular medicine. Popliteal venous Aneurysm.
Schools
University Of North Dakota School Of Medicine
Mayo Clin Grad School Med
Procedures Preformed
- Cardiac Imaging
- Cardiac Myocardial Perfusion Imaging
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- Aortic Valve Disease
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Fellow (FACC)
Education
-
Mayo School of Graduate Medical Education -
University of North Dakota School of Medicine and Health Sciences
Hospital
-
Mayo Clinic - Rochester, Minnesota
Drug Facts
| NPI NUMBER | 1871579862 | |
| NPPES Provider LastName | MCBANE | |
| NPPES Provider FirstName | ROBERT | |
| NPPES Provider ZIPCode | 559050001 | |
| NPPES Provider State | MN | |
| Specialty Description | Cardiology | |
| Total Claim Count | 187.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1871579862 |
| Last Name Of The Provider | MCBANE |
| First Name Of The Provider | ROBERT |
| View All |
Similar Doctors
|
|
Dr. Byron A. Olney, MD |
|
|
Dr. Clarence Shub, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert D. Simari, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alrich L. Gray, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carole A. Warnes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Natalie A. Bottega, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel D. Correa De, MD |
|
|
Dr. Veronique L. Roger, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. R Thomas Tilbury, MD |
|
|
Dr. Thomas M. Munger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Saurabh Sharma, MD |